Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews
Search strategy across alternative databases (queries run on October 14, 2016).
Medline (via PubMed)
#1 Lurasidone Hydrochloride [MeSH Major Topic]
#2 review[Publication Type] OR meta-analysis[Publication Type]
Sets were combined with “OR”
Sets 1–5 were combined with “OR” & “AND”
Most permissive (generic PubMed - no MeSH headings)
((Lurasidone) AND Bipolar) AND review[Publication Type]
#1 “lurasidone”/exp OR lurasidone AND “bipolar depression”:ab,ti AND review:it
(TITLE-ABS-KEY (lurasidone) AND TITLE-ABS-KEY (bipolar disorder)) AND DOCTYPE (re)
“Lurasidone in Title, Abstract, Keywords and ‘bipolar disorder’ in Title, Abstract, Keywords and ‘review’ in Publication Type ”
Note. Words written in italic were used as MeSH headings; the others were used as free text. Proposed entry terms, then accounted as free text integrations: Hydrochloride, Lurasidone Lurasidone HCl HCl, Lurasidone SM 13496 13496, SM SM13496 SM-13496 SM-13,496 SM 13,496 SM13,496 Lurasidone N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3 bicyclo(2.2.1)heptanedicarboximide Latuda.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.